BNP (1-21), Pro (Human) peptide
Not For Human Use, Lab Use Only.
Cat.#: 302612
Special Price 265.70 USD
-
Product Name
BNP (1-21), Pro (Human) peptide
-
Documents
Batch to batch variation of the purity
-
Sequence Shortening
HPLGSPGSASDLETSGLQEQR
-
Sequence
His-Pro-Leu-Gly-Ser-Pro-Gly-Ser-Ala-Ser-Asp-Leu-Glu-Thr-Ser-Gly-Leu-Gln-Glu-Gln-Arg
-
Length (aa)
21
-
Peptide Purity (HPLC)
96.9%
-
Molecular Formula
C89H144N28O35
-
Molecular Weight
2166.31
-
CAS No.
286373-49-7
-
Source
Synthetic
-
Form
Powder
-
Description
BNP (1-21), Pro (Human) refer to the N-terminal portion of the B-type natriuretic peptide precursor (proBNP). ProBNP is a prohormone that, upon enzymatic cleavage after an arginine residue at position 21, yields the mature BNP (1-21) fragment and an N-terminal counterpart. The proBNP (1-21) sequence therefore represents the common analyte generated when intact proBNP and its N-terminal fragments are cleaved by trypsin-like processing, allowing quantification via radioimmunoassay specific for the N-terminal decapeptide. This processing-independent measurement strategy enables detection of total prohormone-derived products in plasma.
In plasma, proBNP concentrations are typically elevated in conditions associated with cardiac dysfunction, reflecting increased secretion from cardiac tissue. The peptide is derived from a larger precursor that undergoes post-translational processing, and the (1-21) fragment serves as a stable marker reflecting the presence of prohormone products. The analytical detection of this fragment relies on the generation of a uniform analyte from both intact proBNP and its N-terminal fragments, with assay imprecision of 12% at 13 pmol/L and 5% at 130 pmol/L within-run. The detection limit of this approach is approximately 0.2 pmol/L.
-
Storage Guidelines
Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details, please refer to the manual: Handling and Storage of Synthetic Peptides
-
References
- Goetze JP, Rehfeld JF, Carlsen J, Videbaek R, Andersen CB, Boesgaard S, Friis-Hansen L. Apelin: a new plasma marker of cardiopulmonary disease. Regul Pept. 2006 Jan 15;133(1-3):134-8. doi: 10.1016/j.regpep.2005.09.032. Epub 2005 Nov 2. PMID: 16263185.
-
About TFA salt
Trifluoroacetic acid (TFA) is a common counterion from the purification process using High-Performance Liquid Chromatography (HPLC). The presence of TFA can affect the peptide's net weight, appearance, and solubility.
Impact on Net Weight: The TFA salt contributes to the total mass of the product. In most cases, the peptide content constitutes >80% of the total weight, with TFA accounting for the remainder.
Solubility: TFA salts generally enhance the solubility of peptides in aqueous solutions.
In Biological Assays: For most standard in vitro assays, the residual TFA levels do not cause interference. However, for highly sensitive cellular or biochemical studies, please be aware of its presence.
- Molar Concentration Calculator
- Dilution Calculator
- Percent Concentration Calculator
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
Related Products / Services
• Peptide Services: NovoPro's peptide synthesis services include standard chemical peptide synthesis, peptide modification, peptide libraries, and recombinant peptide expression.
• Standard Peptide Synthesis: NovoPro offers quality peptides at the most competitive prices in the industry, starting at $3.20 per amino acid. NovoPro provides PepBox – Automatic Quote Tool for online price calculation.
• Peptide Modifications: NovoPro offers a wide range of peptide modification services including isotope labeling (2H, 15N, and 13C), multiple disulfide bonds, multiple phosphorylations, KLH, BSA, ovalbumin, amidation, acetylation, biotin, FITC, etc.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"